Effect of repaglinide on type 2 diabetes
QU Dao-liang
Abstract
QU Dao-liang
Abstract
Objective:To investigate the effects of repaglinide on type 2 diabetes and side effects of hypoglycemia.Methods:One hundred and twenty-four patients with type 2 diabetes were divided randomly into 3 groups,patients in group A were treated with repaglinide,patients in group B were treated with repaglinide and metformin,and patients in group C were treated with repaglinide and α glucosidase inhibitor;the therapy course was 12 weeks;effect of blood glucose control and side effects were observed and compared.Results:Avarage fasting blood glucose 2 hours postprandial blood glucose decrease in patients of group A,B and C were 23.5%,32.6% and 21.8%,32.5 % and 15.7%,29.8 % respectively.Conclusion:Repaglinide alone or combined with other medication can significantly lower fasting blood glucose and postprandial blood glucose of patients with type 2 diabetes,and no hypoglycemia and other serious adverse reactions occure.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of repaglinide on type 2 diabetes and side effects of hypoglycemia.Methods:One hundred and twenty-four patients with type 2 diabetes were divided randomly into 3 groups,patients in group A were treated with repaglinide,patients in group B were treated with repaglinide and metformin,and patients in group C were treated with repaglinide and α glucosidase inhibitor;the therapy course was 12 weeks;effect of blood glucose control and side effects were observed and compared.Results:Avarage fasting blood glucose 2 hours postprandial blood glucose decrease in patients of group A,B and C were 23.5%,32.6% and 21.8%,32.5 % and 15.7%,29.8 % respectively.Conclusion:Repaglinide alone or combined with other medication can significantly lower fasting blood glucose and postprandial blood glucose of patients with type 2 diabetes,and no hypoglycemia and other serious adverse reactions occure.
Key concepts: Repaglinide, Medicine, Postprandial, Hypoglycemia, Metformin, Internal medicine, Type 2 diabetes, Diabetes mellitus